| Megan Mahowald, PHD CCC-SLP | |
|
150 South Road, Mankato, MN 56001-7046 | |
| (507) 389-1415 | |
| Not Available |
| Full Name | Megan Mahowald |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 150 South Road, Mankato, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417244708 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 9386 (Minnesota) | Primary |
| Provider Name | Kid Talk Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1245315027 PECOS PAC ID: 7315190147 Enrollment ID: O20130103000370 |
News Archive
Spatial Integrated Systems, Inc. ("SIS"), a leader in the development and integration of solutions incorporating next-generation digital 3D data capture and processing technologies, announced today that a United States patent application has been published for "system and method for generating structured light for 3-dimensional image rendering" under Publication No. US2009/0169095A1.
Silence Therapeutics plc announces the issuance of United States patent 7,772,203, titled "Methods and Compositions for Controlling Efficacy of RNA Silencing," by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of enhancing RNA silencing with a double stranded RNA interference (RNAi) agent. The patent's RNA silencing method claims include coverage for the administering of a pharmaceutical composition containing short interfering RNA (siRNA), micro RNA (miRNA), pre-miRNA or short hairpin (shRNA) molecules. Silence believes the proprietary structural modification techniques covered in this patent will play a key role in increasing the potential therapeutic efficacy of RNAi therapeutics.
Emisphere Technologies, Inc. today announced that on August 25, 2010, Emisphere Technologies, Inc. entered into a securities purchase agreement with certain institutional investors pursuant to which the Company has agreed to sell an aggregate of 3,497,528 shares of its common stock and warrants to purchase a total of 2,623,146 additional shares of its common stock for total gross proceeds of $3,532,503.28.
Nonin Medical, Inc., a leading innovator of physiological monitoring solutions and the inventor of fingertip pulse oximetry, will demonstrate the World's first Continua(TM) Certified Bluetooth® fingertip pulse oximeter, the Onyx® II, Model 9560, as part of the historic first end-to-end Continua(TM) connected health solution.
› Verified 6 days ago
| Provider Name | Minnesota State Colleges & Universities |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1215000963 PECOS PAC ID: 2264334663 Enrollment ID: O20140121000489 |
News Archive
Spatial Integrated Systems, Inc. ("SIS"), a leader in the development and integration of solutions incorporating next-generation digital 3D data capture and processing technologies, announced today that a United States patent application has been published for "system and method for generating structured light for 3-dimensional image rendering" under Publication No. US2009/0169095A1.
Silence Therapeutics plc announces the issuance of United States patent 7,772,203, titled "Methods and Compositions for Controlling Efficacy of RNA Silencing," by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of enhancing RNA silencing with a double stranded RNA interference (RNAi) agent. The patent's RNA silencing method claims include coverage for the administering of a pharmaceutical composition containing short interfering RNA (siRNA), micro RNA (miRNA), pre-miRNA or short hairpin (shRNA) molecules. Silence believes the proprietary structural modification techniques covered in this patent will play a key role in increasing the potential therapeutic efficacy of RNAi therapeutics.
Emisphere Technologies, Inc. today announced that on August 25, 2010, Emisphere Technologies, Inc. entered into a securities purchase agreement with certain institutional investors pursuant to which the Company has agreed to sell an aggregate of 3,497,528 shares of its common stock and warrants to purchase a total of 2,623,146 additional shares of its common stock for total gross proceeds of $3,532,503.28.
Nonin Medical, Inc., a leading innovator of physiological monitoring solutions and the inventor of fingertip pulse oximetry, will demonstrate the World's first Continua(TM) Certified Bluetooth® fingertip pulse oximeter, the Onyx® II, Model 9560, as part of the historic first end-to-end Continua(TM) connected health solution.
› Verified 6 days ago
| Provider Name | Go Therapy Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1841730876 PECOS PAC ID: 1759651227 Enrollment ID: O20170717003371 |
News Archive
Spatial Integrated Systems, Inc. ("SIS"), a leader in the development and integration of solutions incorporating next-generation digital 3D data capture and processing technologies, announced today that a United States patent application has been published for "system and method for generating structured light for 3-dimensional image rendering" under Publication No. US2009/0169095A1.
Silence Therapeutics plc announces the issuance of United States patent 7,772,203, titled "Methods and Compositions for Controlling Efficacy of RNA Silencing," by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of enhancing RNA silencing with a double stranded RNA interference (RNAi) agent. The patent's RNA silencing method claims include coverage for the administering of a pharmaceutical composition containing short interfering RNA (siRNA), micro RNA (miRNA), pre-miRNA or short hairpin (shRNA) molecules. Silence believes the proprietary structural modification techniques covered in this patent will play a key role in increasing the potential therapeutic efficacy of RNAi therapeutics.
Emisphere Technologies, Inc. today announced that on August 25, 2010, Emisphere Technologies, Inc. entered into a securities purchase agreement with certain institutional investors pursuant to which the Company has agreed to sell an aggregate of 3,497,528 shares of its common stock and warrants to purchase a total of 2,623,146 additional shares of its common stock for total gross proceeds of $3,532,503.28.
Nonin Medical, Inc., a leading innovator of physiological monitoring solutions and the inventor of fingertip pulse oximetry, will demonstrate the World's first Continua(TM) Certified Bluetooth® fingertip pulse oximeter, the Onyx® II, Model 9560, as part of the historic first end-to-end Continua(TM) connected health solution.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Megan Mahowald, PHD CCC-SLP 150 South Road, Mankato, MN 56001-7046 Ph: (507) 389-1415 | Megan Mahowald, PHD CCC-SLP 150 South Road, Mankato, MN 56001-7046 Ph: (507) 389-1415 |
News Archive
Spatial Integrated Systems, Inc. ("SIS"), a leader in the development and integration of solutions incorporating next-generation digital 3D data capture and processing technologies, announced today that a United States patent application has been published for "system and method for generating structured light for 3-dimensional image rendering" under Publication No. US2009/0169095A1.
Silence Therapeutics plc announces the issuance of United States patent 7,772,203, titled "Methods and Compositions for Controlling Efficacy of RNA Silencing," by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of enhancing RNA silencing with a double stranded RNA interference (RNAi) agent. The patent's RNA silencing method claims include coverage for the administering of a pharmaceutical composition containing short interfering RNA (siRNA), micro RNA (miRNA), pre-miRNA or short hairpin (shRNA) molecules. Silence believes the proprietary structural modification techniques covered in this patent will play a key role in increasing the potential therapeutic efficacy of RNAi therapeutics.
Emisphere Technologies, Inc. today announced that on August 25, 2010, Emisphere Technologies, Inc. entered into a securities purchase agreement with certain institutional investors pursuant to which the Company has agreed to sell an aggregate of 3,497,528 shares of its common stock and warrants to purchase a total of 2,623,146 additional shares of its common stock for total gross proceeds of $3,532,503.28.
Nonin Medical, Inc., a leading innovator of physiological monitoring solutions and the inventor of fingertip pulse oximetry, will demonstrate the World's first Continua(TM) Certified Bluetooth® fingertip pulse oximeter, the Onyx® II, Model 9560, as part of the historic first end-to-end Continua(TM) connected health solution.
› Verified 6 days ago
Beth Knoll-fleming, MS, CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 150 St. Andrews Court, Suite 310, Mankato, MN 56001 Phone: 507-388-5437 Fax: 507-388-2108 | |
Kristin Elizabeth Berndt, M.S., CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 119 Clinical Sciences Building, 150 South Rd, Mankato, MN 56001 Phone: 507-389-1543 Fax: 507-389-2821 | |
Monica Anderson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-625-4031 | |
Anne K Erickson, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 708 Mound Ave, Mankato, MN 56001 Phone: 507-345-4576 | |
Theresa Danielle Baranick, CF-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1400 Madison Ave Ste 100aa, Mankato, MN 56001 Phone: 507-594-2600 Fax: 507-594-4810 | |
Mrs. Lisa Kindred, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 30 Hensonshire Ct, Mankato, MN 56001 Phone: 507-469-8780 | |
Erin Elizabeth Krenik, CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1400 Madison Ave Ste 324a, Mankato, MN 56001 Phone: 507-594-2600 |